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In this study, a two-dimensional LC-MALDI-TOF/TOF method has been developed for
analyzing protein complexes. In our hands, the method has proven to be an excellent strategy
for the analysis of protein complexes isolated in pull-down experiments. This is in part because
the preservation of the chromatographic separation on a MALDI target yields an “unlimited”
amount of time to obtain MS/MS spectra, making it possible to probe more deeply into
complex samples. A brief statistical analysis was performed on the data obtained from the
LC-MALDI-TOF/TOF system in order to better understand peptide fragmentation patterns
under high-energy collision conditions. These statistical analyses provided some insight into
how to evaluate the quality and accuracy of the database search results derived from the
TOF/TOF-based analysis. The potential of the method was demonstrated by the successful
identification of all the known penicillin-binding proteins in E. coli isolated using a drug-based
pull-down with ampicillin as the bait. The performance of the LC-MALDI-TOF/TOF system
was compared with that of an equivalent 2D LC-ESI-MS/MS approach, in the analysis of a
protein bait-based pull-down. Regardless of the number of peptides identified in the ESI
versus MALDI approach, the two approaches were found to be complementary. When the
data is merged at the peptide level, the combined result gives higher Mascot scores and an
overall higher confidence in protein identification than with either approach alone. (J Am Soc
Mass Spectrom 2004, 15, 803–822) © 2004 American Society for Mass SpectrometryHistorically, the analysis of proteins was typi-cally an endeavor in which a single protein ofinterest was studied at a time in a given re-
search project. Such efforts were generally categorized
as being within the field of protein biochemistry, al-
though the project may have originated in any of a
variety of other fields. Changing technology has led to
a shift from the paradigm of the analysis of single
proteins to the analysis of large collections of proteins.
This shift was enabled by a variety of new technologies
and was sufficiently fundamental that a new term was
coined to describe this alternative approach, namely
proteomics. The term proteomics was first coined in
1995, and was defined as the large-scale characteriza-
tion of the protein complement to a genome [1]. Since
then, the definition has been expanded to include
almost anything to do with the large-scale analysis of
proteins or their function; including, for example, pro-
tein expression, function, 3D structure, sub-cellular
localization and post-translational modification [2–4].
Whereas the term proteomics originated in the mid-
1990s, one can argue that the field of proteomics began
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doi:10.1016/j.jasms.2004.02.004with the advent of two-dimensional (2D) gels, approx-
imately 20 years earlier [5, 6]. Two-dimensional gels
afforded the ability to resolve and visualize complex
protein mixtures. Initially, this approach suffered from
the lack of techniques that allowed the ready identifi-
cation of the protein spots that were isolated from the
gels. However, since the first use of 2D-gels, there have
been tremendous advances in related technologies,
most notably, in the area of biological mass spectro-
metry. The ability to efficiently and gently generate ions
from biological molecules was a prerequisite for the
technology to progress to its current state. The advent of
electrospray ionization (ESI) [7] and matrix-assisted
laser desorption/ionization (MALDI) [8] made it possi-
ble to analyze large biomolecules on a routine basis for
the first time.
Since ESI is a technique that generates ions from a
liquid stream, it was relatively straightforward to cou-
ple that ionization method with on-line liquid chroma-
tography. Furthermore, ESI generates multiply charged
ions that effectively increases the mass range of a mass
spectrometer, thereby enabling the use of quadrupole
mass analyzers in conjunction with ESI. As early as
1989, it was demonstrated that a triple quadrupole
instrument could be used to fragment the multiply
charged molecular ions produced by ESI [9]. This
capability made it possible, under favorable circum-r Inc. Received December 4, 2003
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of a peptide. Relatively soon thereafter, Covey et al.
demonstrated that tandem mass spectrometry (MS/
MS) could be combined with online liquid chromatog-
raphy (LC/MS/MS) via ESI to yield peptide sequence
information from complex mixtures [10]. From this
early beginning, ESI-MS/MS has dominated the analy-
sis of complex peptide mixtures.
In contrast to ESI, MALDI ionization, as originally
applied to protein identification, relied on a fingerprint-
ing approach [11, 12]. This was, in part, due to the fact
that MALDI was first implemented on a time-of-flight
(TOF) mass analyzer. These systems originally were not
capable of generating MS/MS data and even after the
discovery that peptides could be sequenced by post-
source decay (PSD) [13], MALDI-TOF MS systems were
not as capable of routinely yielding peptide sequence
information as ESI-MS/MS systems. The consequence
of this limitation was that MALDI systems were pri-
marily used to identify proteins by MS-only measure-
ments of enzymatic digests and subsequent peptide
mass fingerprinting (PMF). As it turned out, PMF was
complementary to the 2D-gel separation approach com-
monly used to separate complex protein mixtures.
When visualization of a 2D-gel revealed a protein of
potential interest, the spot in question was excised from
the developed gel, subjected to proteolysis and the
resultant set of peptides was analyzed by MALDI-MS to
identify the protein by PMF. That approach was sensi-
tive and rapid when compared to the time required to
analyze the extracted peptides by LC/MS/MS. The
inherent drawback, however, was that the technique
required the sample be derived from only one protein
or at most a few proteins. Thus, the MALDI-MS peptide
mass fingerprinting approach was not amenable to the
analysis of protein complexes unless it was used in
conjunction with 2D-gels.
The drawbacks to using 2D-gels and MALDI-MS for
protein identification have become apparent as the
technique has become more widespread [14]. While
strides have been made in making 2D-gel analysis
reproducible and automated, significant work still
needs to be done to bring it to the level of the automa-
tion routinely achieved in an LC/MS analysis. Even if
these limitations are adequately addressed, 2D-gels
suffer from inherent systematic biases that prevent the
detection of many proteins. The magnitude of this
problem is perhaps best illustrated by the work of
Langen et al. [15]. In their study to characterize the
proteome of Haemophilus influenzae, they performed a
variety of pre-fractionation steps prior to 2D-gel sepa-
ration of the Haemophilus proteins. This strategy was
part of an attempt to be as comprehensive as possible in
their identification of proteins from this fairly simple
organism. In spite of their efforts, they only identified
502 different proteins of the 1742 predicted from the H.
influenzae genome.
The coupling of MALDI to mass spectrometers with
MS/MS capability [16–20] has afforded the opportunityto decouple MALDI-MS from 2D-gels. However, with-
out the separation capability of HPLC, MALDI-MS
systems have continued to be limited in their ability to
analyze complex peptide mixtures derived from multi-
ple proteins. The power of such an LC-MS approach
when coupled with ESI-MS/MS has been amply dem-
onstrated. Furthermore, the ability to sequentially cou-
ple orthogonal LC techniques has made it possible to
bypass gels completely when analyzing protein com-
plexes by ESI-MS/MS [21–23]. In contrast, the coupling
of LC to MALDI has only recently been achieved with
any degree of success for peptide analysis [24–26].
Since MALDI has been shown to be complementary
to ESI with respect to the population of peptides and
proteins that may be detected [27–29], we decided to
combine liquid chromatography with MALDI-MS/MS
and compare the results with those obtained from an
analysis of the identical samples by ESI-MS/MS. In this
study, we used a new type of MALDI-MS/MS system
(a so-called TOF/TOF) and compared it with an LCQ
Deca XP, since the latter instrument has been applied to
the analysis of protein complexes with a significant
level of success [21–23]. Because chromatography is
such an integral component for the success of ESI-based
protein analysis, it seemed appropriate to do the com-
parison based on 2-dimensional chromatographic sep-
aration as the method of sample introduction to both
instrument platforms. In the case of the MALDI system,
the coupling of reverse-phase chromatography to
MALDI ionization has not been well established or
described in the literature. Therefore, this paper also
seeks to illustrate some of the optimizations that were
necessary to achieve the results described herein. Ad-
ditionally, the LC-MALDI data has been subjected to
some simple statistical analyses to identify basic trends
in the results. Finally, some comment is made on the
optimal strategy to combine the protein identification
results achieved from these separate approaches. The
power of this combined strategy is illustrated in the
analysis of the protein complexes.
Experimental
Chemicals
Sequencing-grade tryspin was purchased from Pro-
mega (Madison, WI). All protein standards and
-cyano-4-hydroxy-cinnamic acid (CHCA) were ob-
tained from Sigma-Aldrich (St. Louis, MO). CHCA was
re-crystallized from water before being used and the
proteins were used as provided. Acetonitrile (ACN;
Optima grade) was purchased from Fisher Scientific
International Inc. (Pittsburgh, PA), and trifluoroacetic
acid (TFA) was purchased from J. T. Baker (Phillips-
burg, NJ). The water used in this study was purified
using a Milli-Q water purification system from Milli-
pore (Bedford, MA).
A protein mixture (10 protein mix) was used in
method development. This sample consisted of 55%
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proteins were phosphorylase B, ovalbumin, alcohol
dehydrogenase, carbonic anhydrase, myoglobin, -lact-
albumin, hemoglobin, lysozyme, and cytochrome c,
each of which accounts for 5% of the total sample
amount by weight. Another protein mixture (T2 mix),
comprised of four proteins, was also used during
method development. That sample consisted of a mix-
ture of hemoglobin, lysozyme, ovalbumin and -lactal-
bumin in a 2:2:2:1 molar ratio.
The 4700 Proteomics Analyzer calibration mixture
(4700 mix) was obtained from Applied Biosystems
(Foster City, CA). The standard preparation of the
calibration mixture contains des-Arg-Bradykinin (1.0
pmole/L), Angiotensin I (2.0 pmole/L), Glu-Fibrino-
peptide B (1.3 pmole/L), ACTH (1-17 clip) (2.0
pmole/L), ACTH (18-39 clip) (1.5 pmole/L), and
ACTH (7-38 clip) (3.0 pmole/L). A 10-fold dilution of
the standard 4700 mix was used as the calibrant for the
MALDI plates on which LC fractions were spotted.
Ampicillin Pull-Down
The procedure for isolating penicillin-binding proteins
using ampicillin as the bait is described in Ref. [30].
Briefly, Ampicillin was first immobilized to M-270
epoxy magnetic beads (Dynal Biotech, Oslo, Norway),
which were then incubated with solubilized E. coli
membrane. After the incubation, the supernatant was
removed, and the beads were washed with the membrane
solubilization solution (10 mM Tris-HCl, 150 mM NaCl,
1% Triton X-100, pH 7.5). A second wash was performed
with a 0.2% N-lauroylsarcosine solution to remove any
non-specific or non-covalently bound proteins. Proteins
that were covalently bound to the immobilized ampicillin
were released by in situ digestion using trypsin.
GRB2 Pull-Down
One mL of 5 mg/mL HeLa whole cell lysate was
incubated for 1.5 h rotating at 4 °C in a 15 L bed of
glutathione (GSH) beads (Amersham Biosciences, Pis-
cataway, NJ) bound to 30 g of the tandem tagged
growth factor receptor-bound protein 2 (GRB2) with
gluathione-S-transferase (GST) and hexa-histidine tags.
The samples were briefly centrifuged to pellet the beads
and the lysate was removed. Beads were transferred to
clean Eppendorf tubes and washed three times each
with 1 mL pull-down buffer (20 mM HEPES, pH 7.5,
150 mM NaCl, 10% glycerol, 0.1% NP-40). Bound pro-
teins were eluted in three fractions using 50, 50, and 100
L of pull-down buffer containing 0.2% N-lauroylsar-
cosine, and the eluates were combined. The eluates
were spiked with 10 mM imidazole and incubated with
a 10 L bed of Ni-NTA agarose beads (Invitrogen,
Carlsbad, CA) for 30 min at 4 °C to reduce the amount
of bait in the sample. The supernatant from the nickel
beads was collected and a 10 L aliquot of each sample
was analyzed by SDS-PAGE. The remainder of the
isolated proteins was ethanol-precipitated in order toreduce the amount of detergent, prior to mass spectro-
metric analysis.
In-Solution Digestion
Urea method. Five L of a protein solution containing 5
to 10 g of total protein was added to 25 L of 8 M
urea/0.2 M NH4HCO3 solution in an Eppendorf tube.
Subsequently, five L of 45 mM dithiothreitol (DTT)
was added, and the tube was incubated at 60 °C for 15
min. The solution was allowed to cool to room temper-
ature, and then 5 L of 100 mM iodoacetamide was
added to the tube. The solution was incubated at room
temperature in the dark for 15 min. The urea was
diluted to a final concentration of 2 M by the addition of
60 L of H2O. Trypsin was added to the tube at a
protein/enzyme ratio of 20:1 by weight, and the solu-
tion was incubated at 37 °C for at least 2 h.
SDS method. The SDS digestion method is similar to
the urea method described above, except that the pro-
tein sample was first added to 25 uL of 0.2 M
NH4HCO3/0.1% SDS solution. The proteins were dena-
tured by heating at 100 °C for 5 min, and were allowed
to cool to room temperature. The reduction and alkyla-
tion steps that followed were the same as those de-
scribed above in the urea method. After alkylation, the
SDS was diluted to a concentration of 0.02% (wt/vol) by
adding 70 L of H2O and 15 L of ACN to the
Eppendorf tube. Trypsin was added to the solution at
the same protein/enzyme ratio as above, and the solu-
tion was incubated at 37 °C for at least 2 h.
Peptide desalting. Tryptic peptides were desalted using
a peptide MicroTrap cartridge (Michrom BioResources,
Auburn, CA) before being loaded onto a strong cation-
exchange (CEX) column or a reverse-phase HPLC (RP-
HPLC) column. The trap was conditioned with 100 L
of Reagent A (0.1% TFA in 95% ACN), and was then
equilibrated twice with 100 L of Reagent B (0.5% acetic
acid  0.1% TFA in water). The digested sample was
acidified with 10% TFA and then loaded onto the trap.
The flow-through volume was loaded onto the trap one
more time to ensure complete binding of the peptides.
The trap was subsequently washed with 50–70 L of
Reagent B, and the peptides were eluted with 50–70 L
of Reagent A. The desalted sample was concentrated
using a CentriVap vacuum centrifuge (Labconco, Kan-
sas City, MO), and was resuspended in 5.5 L of 0.5%
acetic acid/2% ACN prior to CEX injection.
Strong Cation-Exchange Fractionation
Desalted peptides that were derived from the tryptic
digestion were separated on a Vydac 400VHP series
strong cation-exchange column (0.3  50 mm) (Grace
Vydac, Hesperia, CA); using an Agilent 1100 series
binary pump (Agilent, Palo Alto, CA). Buffer A was
0.5% acetic acid/20% ACN, and Buffer B was 250 mM
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HPLC pump flow-rate was 300 L/min, which was
split down to a column flow-rate of 4 L/min. The CEX
effluent was collected using a Probot micro fraction
collector (LC-Packings, Sunnyvale, CA), and the CEX
fractions were concentrated using a CentriVap vacuum
centrifuge.
Several combinations of CEX gradients and numbers
of collected fractions were employed in this study. The
two-CEX-fraction method employed the following gra-
dient: 0–10 min, 0% B; 10–20 min, 10% B constant;
20–35 min, 100% B constant. The eluent from the first 20
min of the gradient was collected in the first fraction.
The second fraction contained the eluent from the 15
min of 100% B washing step. The gradient for the
three-CEX-fraction method was: 0–10 min, 0% B; 10–30
min, 0–20% B; 30–40 min, 100% B constant. Three
fractions were collected sequentially for 20 min, 10 min,
and then another 10 min. Finally, the gradient for the
six-CEX-fraction method was: 0–10 min, 0% B; 10–34
min, 0–40% B; 35–46 min, 40–100% B. In this case, six
fractions were collected sequentially with one fraction
for the first 10 min, and three following fractions for 6
min each and then two more fractions for 10 and then 12
min. All of the collected fractions were subsequently
taken to dryness using a vacuum centrifuge.
Reverse-Phase-HPLC Separation
Prior to reverse-phase HPLC (RP-HPLC), the collected
fractions were re-suspended in 5.5 L of 0.5% TFA.
Reverse-phase HPLC was performed using a 75 m 
150 mm column (LC-Packings), and the samples were
injected using a Famous autosampler and a Switchos II
system (LC-Packings). The samples were first loaded
onto a 5 mm trap cartridge for in-line desalting and then
were back-eluted onto the analytical column for the
separation step. The HPLC gradient was controlled by
an UltiMate HPLC system (LC-Packings). Solvent A
was 0.1% TFA in water, and Solvent B was 0.1% TFA in
100% ACN. The flow-rate was 250 nL/min. The follow-
ing gradient was used for the peptide separation: 0–6.5
min, 2–14% B; 6.5–41.5 min, 14–35% B; 41.5–51.5 min,
35–55% B; 51.5–52.5 min, 55–80% B, and 52.5–56.5 min,
80% B constant. The HPLC eluent was directly mixed
with MALDI matrix at a flow rate of 800 nL/min via a
Micro Tee fitting (Upchurch Scientific, Oak Harbor,
WA) before being deposited on a barcoded blank
MALDI plate (Applied Biosystems) using a Probot
micro fraction collector. The CHCA MALDI matrix that
was mixed with the HPLC eluent was made up at a
concentration of 3 mg/mL in 70% ACN with 0.1
mg/mL of ammonium acetate. Spots were deposited
every 20 s, and a total of 144 spots were collected in a 12
 12 array for each HPLC run. Six external calibration
spots, containing 10-fold diluted 4700 mix, were man-
ually spotted across the plate, with two spots in the
middle and four at the four corners of the LC-MALDI
plate (Figure 1).Mass Spectrometry
MALDI-MS. Samples were analyzed using either a
Voyager-DE STR MALDI-TOF (Applied Biosystems) or
a 4700 Proteomics Analyzer MALDI-TOF/TOF (TOF/
TOF, Applied Biosystems). When necessary, the sam-
ples were first desalted using micro C18 ZipTips (Mil-
lipore, Bedford, MA), and the peptides were eluted
directly with 5 mg/mL of CHCA in 60% ACN/0.1%
TFA onto a MALDI plate. All MS spectra were recorded
in positive reflector mode. For MS data, 200 shots were
accumulated for each spectrum obtained from the Voy-
ager-DE STR, and 1000 shots from the TOF/TOF.
MALDI-MS/MS. All MS/MS data from the TOF/TOF
was acquired using the default 1kV MS/MS method
that was created when the instrument was installed by
the manufacturer. MS/MS data acquisition from the
plates (LC-MALDI plates) on which the LC eluent had
been spotted by the Probot was performed in a four-
step process. First, MS spectra were recorded from each
of the six calibration spots, and the default calibration
parameters of the instrument and the plate model for
that plate were updated. Second, MS spectra were
recorded for all 144 sample spots on that plate. Each
spectrum was generated by accumulating the data from
750 laser shots using the newly updated default calibra-
tion settings. Third, the 144 MS spectra were analyzed
using the Peak Picker software supplied with the in-
strument. Spectral peaks that met the threshold criteria
and were not on the exclusion list were included in the
acquisition list for the MS/MS portion of the experi-
ment. The threshold criteria were set as follows: mass
range: 650 to 4000 Da; minimum cluster area: 500;
minimum signal-to-noise (S/N): 10; Peaks/spot: 30;
maximum precursor gap: 200 ppm; maximum fraction
gap: 4. A mass filter excluding matrix cluster ions (see
below) was applied. An XML file was generated that
contains the list of the precursor masses selected for
Figure 1. Picture of a barcoded LC-MALDI plate with 144
sample spots and 6 calibration spots. The 6 calibration spots are
highlighted with circles.
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the list was imported into the 4700 Explorer software
batch editor, and MS/MS spectra were recorded using
air as the collision gas with 1kV collision energy setting.
During MS/MS data acquisition, a method with a
stop condition was used. In this method, a minimum of
750 shots (6 sub-spectra accumulated from 125 laser
shots each) and a maximum of 2000 shots (16 sub-
spectra) were allowed for each spectrum. The accumu-
lation of additional laser shots was halted whenever at
least 10 ions with a S/N of at least 10 were present in
the accumulated MS/MS spectrum, in the region from
m/z 400 to 90% of the precursor mass.
The scanning MS/MS experiment that was used to
examine the matrix background was performed as
follows. CHCA matrix by itself was prepared and
spotted on a MALDI target using the standard protocol.
The timed-ion-selector (TIS) window was set to a width
of 10 Da. A series of MS/MS spectra was acquired in
which each subsequent spectrum had the mass setting
of the TIS incremented upwards by 10 Da from m/z 600
to 1200, and then four additional spectra were acquired
in which the TIS setting was adjusted in 50 Da steps.
The intensity in counts of the base peak of each of the
spectra was plotted versus the mass setting of the TIS.
ESI-MS/MS. ESI-MS/MS was performed using an
LCQ Deca XP instrument (ThermoFinnigan, San Jose,
CA). An identical RP-HPLC system as was described
above for the LC-MALDI set-up was also used to
perform the ESI-based LC/MS/MS experiments. For
these experiments, the LCQ was equipped with a cus-
tom-built ESI source (James Hill Instrument Service,
Boston, MA). The peptide mixtures derived from the
CEX fractions were separated using a 75 m  15 cm
column (LC-Packings) equilibrated in 0.5% acetic acid
and 2% acetonitrile flowing at 250 nL/min. A linear
gradient from 2 to 50% B in 50 min was used to elute the
peptides. Data was acquired in a data-dependent mode
using 1 MS scan followed by 3 MS/MS scans of the
three most abundant peaks, unless they were excluded
by a dynamic exclusion window of 3 min.
Protein Identification by Database Searching
Data from PMF experiments performed on the Voyager-
DE STR was analyzed primarily using the Proteomic
Solution 1 system (Applied Biosystems), with Protein
Prospector as the search engine. A maximum of 150
peaks was submitted for database searching against a
small database composed of the sequences of the pro-
tein standards only.
Data obtained from the TOF/TOF and LCQ were
searched using Mascot (Matrix Sciences, London, UK)
as the search engine. All searches were performed
against either the NCBInr protein sequence database or
the human subset of that database. In the latter case, a
separate database was constructed to contain only hu-
man proteins (HumanNR). GPS Explorer (Applied Bio-systems) was used for submitting data acquired from
TOF/TOF for database searching. Data from the LCQ
was submitted to the Mascot server via custom soft-
ware. That custom software used the output from the
LCQDTA.EXE program provided by the manufacturer,
but prior to submission to the Mascot server, the
software combined the peak lists generated from the
separately analyzed CEX fractions into one peak list.
The Mascot searching was performed using the default
settings for the specific instrument type as supplied by
Matrix Science, except that ions with a score below 10
were excluded from the results.
Results and Discussions
The overall process flow for analyzing a protein com-
plex using the LC-MALDI approach is described in
Scheme 1. Protein complexes were first digested using
trypsin, and the tryptic peptides were subsequently
separated on a strong cation-exchange column. Pep-
tides in the fractions from CEX chromatography were
further separated by reverse-phase HPLC, and the
HPLC eluent was mixed online with MALDI matrix
and then directly spotted onto a MALDI target. The MS
Scheme 1. The process flow of protein identification using
LC-MALDI.
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plate using MALDI-TOF/TOF in the MS mode, and
then all MS spectra were globally analyzed using the
Peak Picker software. This software created an output
file that contained a list of peaks to be analyzed by
MS/MS. Using this output file from the Peak Picker
software, MS/MS spectra were recorded next, and after
processing to generate peak lists for each MS/MS
spectrum, the data was submitted for database search
using Mascot as the search engine. Many of the steps in
the process were optimized. The various optimizations
described below are in essentially the order outlined in
the description of the LC-MALDI process in Scheme 1.
In-Solution Digestion Methods Comparison
Regardless of the separation method used, identifica-
tion of proteins by MS/MS generally requires the prior
enzymatic digestion of the proteins to peptides of a
suitable size. Trypsin is the most widely used endopro-
teinase in this application as it yields many peptides in
the 1–2 kDa range, and because those peptides have a
basic C-terminus that is often ideal for yielding frag-
ments that indicate the sequence of the peptide. In order
to maximize digestion efficiency, it is generally neces-
sary to denature the protein or proteins of interest prior
to digestion to render them accessible to the proteinase.
Incomplete digestion will yield larger fragments which
can generally be more difficult to fragment in an
MS/MS experiment. In the case of the TOF/TOF, there
is in principal no limit to the size of the peptide that can
be selected for MS/MS, and the high-energy collision
conditions typically employed would seem to offer an
advantage for fragmenting larger peptides. The poten-
tial advantage in working with larger peptides is that
the mixture of peptides produced from a collection of
proteins is generally less complex. Because the TOF/
TOF is a new class of instrument for which we had no
clear indication of the relative benefits of different
digestion strategies, we decided to compare two com-
mon digestion strategies.
The two most commonly used denaturing reagents
are urea and SDS; however, there is no reported study
to our knowledge on comparing the effects of these two
denaturing reagents on protein digestion, especially as
it relates to MALDI-MS/MS analysis. In solution, and at
elevated temperature, urea can be decomposed to iso-
cyanic acid, which reacts with the primary amine
groups to form a carbamylated protein or peptide. This
modification will change the mass of the peptides, and
affect any subsequent database search. On the other
hand, the presence of SDS is known to suppress the
MALDI process, and it also affects the peptide separa-
tion in an RP-HPLC column. Additionally, denatured
trypsin may undergo autolysis, thereby generating
pseudotrypsin, which exhibits a chymotrypsin-like ac-
tivity [31], and cleaves after aromatic residues. The
chymotryptic activity of trypsin will also interfere with
database searching. Although most of the commerciallyavailable trypsins have been modified to make them
more stable, autolysis activity is still evident, as indi-
cated by the presence of m/z 842, 1045, and 2211
fragments.
A time-course study on protein digestion was per-
formed using either a urea- or SDS-based method. The
study employed protein standards, including BSA, car-
bonic anhydrase, ovalbumin, and -lactalbumin. After
the addition of the trypsin to the protein solutions, an
aliquot of the sample was removed at 5, 15, 30, 60, 90,
and 120 min, and the trypsin activity was quenched
with TFA; samples were analyzed by MALDI-MS. In as
few as 5 min after the addition of trypsin, tryptic
peptides, including several large ones in the range of
3–4 kDa, were observed for all of the proteins tested in
either method. Prolonged incubation gradually reduced
the intensity of the larger peptides. A database search
by the PMF method indicated that the protein sequence
coverage at 5 min for each of the four proteins tested
was equal to or slightly greater than the coverage
obtained after 30 min of digestion. Generally, all the
digestions are complete after a 60-min incubation.
In comparing the data from the two digestion ap-
proaches, it was determined that SDS digestion method
yielded a more complete digestion under the conditions
used, and with fewer missed cleavages. At the 30-min
time point, more high molecular weight peptides were
observed in the samples from the urea digestion
method (Figure 2). However, the sequence coverage for
most of the proteins tested was slightly higher using
urea digestion method at any equivalent time point.
The chymotryptic activity of trypsin in the two
digestion protocols used was examined by looking for
chymotryptic fragments in the digests of ovalbumin
and -lactalbumin. In each case, only one chymotryptic
peptide was observed in the samples from urea diges-
tion. Furthermore, no additional peaks were detected
that might correspond to carbamylation of the tryptic
peptides. In the SDS digestion method, an average of
three chymotryptic peptides was detected, suggesting
that the presence of SDS in the digestion solution
renders trypsin more susceptible to autolysis. Addition-
ally, the slightly larger peptides that are produced by
the urea-based digestion had no impact on the quality
of the protein identifications derived from the MS/MS
data generated on the TOF/TOF. Given the above
results, the urea-based method was employed in sub-
sequent experiments.
Strong Cation-Exchange Separation Optimization
Given the ion suppression phenomenon associated with
both ESI- and MALDI-based [32, 33] analyses of com-
plex mixtures, and given the MS/MS duty-cycle limita-
tion of an online ESI-LC/MS/MS-based approach, bet-
ter peptide separation prior to LC/MS/MS analysis is
critical for identifying low abundance proteins in a
mixture. The degree of separation that is required is
dependent on sample complexity and its impact on ion
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analysis. The use of 2D LC techniques has become fairly
routine to optimize peptide separation in complex mix-
tures for ESI-MS [21–23], but the appropriate imple-
mentation of this strategy for MALDI-MS/MS re-
mained to be investigated.
Peptide separation on a CEX column. Peptide retention
on a CEX column is primarily based on electrostatic
interactions between the positive charges on the pep-
tides and the negative charges on the stationary phase.
However, the hydrophobicity of a peptide has been
shown to play a role on the retention time, and the
presence of organic modifier in the mobile phase will
affect the peptide retention time. To test the effect of the
presence of ACN in the mobile phase on peptide
separation, 2 g of peptides from the 10 protein mix
was separated on a Vydac CEX column in the presence
of 2 or 20% ACN. Eight CEX fractions from a step
gradient elution were collected at 0, 10, 20, 30, 40, 60, 80,
and 100% B with 10-min collections at each step. The
samples were desalted using a C18 ZipTip, and the MS
spectrum for each fraction was recorded using the
TOF/TOF. Ions with a S/N of 10 and higher were
submitted for database search against a small database
consisting of the 10 standard proteins only.
The CEX separation proved to be very effective, with
most of the peptides resolved into a single CEX fraction
(Figure 3). With 2% ACN in the mobile phase, an
average of 105 peptides was identified in the eight CEX
fractions in replicate experiments, accounting for 86
unique tryptic peptides. However, an average of 190
peptides, of which 120 are unique, was identified in the
eight fractions from the experiments with 20% ACN in
the mobile phase. The presence of the organic modifier
apparently helped the elution of some strongly retained
peptides.
Figure 2. MS spectra of tryptic peptides from c
digestion methods after 30 min incubation at 37In addition to the detection of more peptides, the
presence of 20% ACN in the mobile phase caused some
peptides to elute much earlier than when 2% ACN was
used (Figure 3). With 2% ACN in the mobile phase, the
largest proportion of the peptides was present in the
third CEX fraction. In contrast, with the addition of 20%
ACN to the mobile phase, the largest proportion of
peptides was found to be in either the flow-through or
the second fraction with 10% B.
At first glance, there was no significant tailing of the
peptides in either buffer system (Figure 3). However,
the 20% ACN conditions exhibited an anomalous
“hump” late in the gradient for some peptides. Closer
examination of the spectra revealed that this late-elut-
ing hump corresponds to low abundance signals of
previously eluted peptides. Since the organic portion of
ic anhydrase using the SDS (a) and the urea (b)
Figure 3. The effect of organic modifier on peptide separation on
a CEX column. The MALDI ion intensities for peptide YLYEIAR
(m/z 927.49) from BSA in the eight CEX fractions were plotted. The
solid line indicates the experiment that contained 20% ACN in the
mobile phase, whereas the dashed line indicates the experiment
that contained 2% ACN in the mobile phase.arbon
°C.
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reason to expect a sudden elution of “sticky peptides”
late in the CEX gradient of the 20% ACN buffer system
and not in the 2% ACN buffer system. Additionally,
increasing the ACN concentration to 25% did not have
a significant effect on the elution profile and, at that
concentration, the salts in the buffer start to precipitate.
Ultimately, the “hump” was attributed to tailing of
previously observed peptides. The reason they were not
detected in the intervening fractions was because they
were suppressed by the high-abundance of late-eluting
peptides. In the case of the 2% ACN buffer system the
concentration of the late-eluting peptides never fell off
rapidly enough to reduce the suppression and thereby
allow the observation of the tailing peptides as a
“hump”. Given that additional peptides were observed
when using the buffer system with 20% ACN, that
system was adopted for subsequent analyses.
When the peptide distribution among the eight frac-
tions collected was analyzed in more detail (Table 1),
most of the neighboring fractions shared some peptides.
However, in the last three CEX fractions, the majority of
the identified peptides were present in all three frac-
tions. Consequently, these fractions were combined in
subsequent analyses to avoid diluting those peptides
into several fractions.
Step versus linear gradient elution. The effect of using a
step gradient elution versus a linear gradient elution
was also evaluated. The linear gradient method em-
ployed two linear segments in which the B buffer was
ramped from 0 to 40% in 40 min and from 40 to 100% in
30 min. The flow-through plus seven additional frac-
tions were collected each for 10 min. In the linear
gradient elution, peptides were found to elute from the
column slightly later than those in a comparable step
gradient elution experiments. The overall peptide dis-
tributions in all eight fractions are similar in both
experiments; however, a slightly higher number of
unique peptides was identified in repeated experiments
with linear gradient elution (data not shown). That
result suggests that linear gradient separation is gener-
Table 1. Peptide distribution in CEX fractions
Fraction
(B%) 0% 10% 20% 30% 40% 60% 80% 100%
No.
peptides 36 27 29 24 15 21* 25* 28*
0% 7§ 1§ 0§ 1§ 1§ 4§ 7§
10% 4§ 1§ 0§ 3§ 4§ 7§
20% 6§ 2§ 7§ 12§ 12§
30% 4§ 5§ 7§ 7§
40% 4§ 5§ 6§
60% 11§ 13§
80% 24§
*37 unique peptides out of the 74 identified in these three fractions.
§The number of common peptides present in the two fractions cross
compared.ally better than step gradient separation. Consequently,
the linear gradient was adopted for subsequent
experiments.
Reverse-Phase HPLC Separation
In the LC-MALDI experiments, RP-HPLC was not cou-
pled directly with the MALDI-TOF/TOF systems. The
eluent from the column was mixed with the MALDI
matrix before being deposited directly onto a MALDI
plate. The fractions were collected onto the MALDI
plate at 20 s intervals, which corresponded to a volume
of 350 nL per spot. As illustrated in Figure 4, the
extracted ion chromatogram of a tryptic peptide from
hemoglobin exhibited a sharp chromatographic peak
with negligible chromatographic dispersion. In princi-
pal, continuous deposition of the sample would best
preserve the fidelity of the chromatographic separation.
The minimal dispersion exhibited in this system, how-
ever, suggests that the discrete deposition does not have
a major impact on the chromatography. Furthermore,
when the surface area of a continuous track is compared
to that of the discrete spots used in this analysis (Figure
1), it is clear that the reduced surface area that needs to
be sampled from the discrete spots minimizes the total
analysis time of the experiment. Furthermore, each
peptide is also at a higher concentration in a spot versus
a track.
The morphology of the matrix crystals is affected by
the organic composition in the solution, and that mor-
phology affects peptide ionization. The effect of differ-
ent concentrations of ACN in MALDI matrix on crystal
formation was analyzed. 250 fmole of tryptic peptides
from T2 mix were separated on the RP-HPLC column,
and the HPLC eluent was mixed with CHCA prepared
in either 50, 60, or 70% ACN. The protein sequence
coverage for T2 mix proteins obtained under those
different conditions was compared.
With 70% ACN in the matrix, the on-spot ACN
concentrations vary from 53% to 72% from the first to
the last spot collected on the MALDI plate. Crystal
morphology under those conditions was found to be
Figure 4. Chromatogram of peptide separation in RP-HPLC. The
MALDI ion intensities in the 144 spots for a peptide with a mass
of m/z 1221.68 from hemoglobin -chain were plotted. This pep-
tide was found predominately in spot 71.
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Crystals formed at a lower ACN concentration were
generally much larger, and those formed at a higher
ACN concentration were much smaller with non-uni-
form sizes. There was no obvious difference on the
protein coverage obtained with different ACN concen-
tration for the four proteins present in the sample.
However, an even distribution of matrix crystal within
the sample spot should lead to a more efficient sam-
pling of the spot by the laser, as compared to the
situation where the laser hits more gaps in the crystals
where there is uneven crystal distribution.
Crystal morphology can also affect the rate at which
the matrix is ablated from the MALDI target at a given
laser power setting. Consequently, the effect of ACN
concentration on the sample depletion rate was tested
by recording replicate 10 MS/MS spectra for a tryptic
peptide from hemoglobin -chain at m/z 1265.9. The
MS/MS spectra, accumulated from 1000 laser shots
each, were recorded for each set of solvent conditions
described above. The intensities of three fragment ions,
which correspond to a b-ion, a y-ion, and an internal
fragment ion, were plotted (data not shown) after the
replicate spectra were acquired. No obvious difference
in the sample depletion rate, as determined from the
intensity of the monitored fragment ions, was observed
for the crystals formed from the different solvent sys-
tems. Given that the earlier experiments exhibited more
uniform crystal formation from 70% ACN, that solvent
system was adopted for all subsequent experiments.
TOF/TOF Method Optimization
The development of MALDI-TOF/TOF instruments
promises the capability of acquiring MALDI-MS/MS
data with significantly improved automation capabili-
ties as compared with MALDI-PSD analysis [34].
MALDI-TOF/TOF technology, however, is still suffi-
ciently new that the optimum operational parameters
and instrumental settings still must be determined.
Some of those parameters are likely to be instrument-
specific and consequently may not apply to all MALDI-
TOF/TOF instrument brands.
The focus of this study is the application of an
Applied Biosystems MALDI-TOF/TOF to the analysis
of samples obtained from an LC separation (LC-
MALDI-TOF/TOF). The principal advantage of using
MALDI-based ionization for the analysis of LC-sepa-
rated samples is that the duty-cycle of the experiment is
essentially unlimited, owing to the fact that the chro-
matographic separation is preserved almost indefinitely
in the dried spots on the MALDI target. Consequently,
there is a nearly unlimited amount of time available to
make decisions about the signals to select for MS/MS.
Furthermore, the decision process may be made after
the MS analysis of the entire separation is complete.
This last property makes it possible to obtain MS/MS
spectra for peptides at the chromatographic peak max-
ima to ensure the acquisition of the best possible spectrafor a given amount of sample. In Figure 4, the peptide
with a mass of m/z 1221.68 was found in spot 70 to spot
73; however, it is most concentrated in spot 71. In this
case, MS/MS acquisition was done only on spot 71 for
that peptide. This mode of acquisition differs from an
online ESI-LC/MS/MS experiment in which MS/MS
spectra are acquired as soon as a signal meets the
minimum threshold conditions, because the data sys-
tem has no way of knowing whether the signal will
continue to increase in time or decrease.
Acquisition Method Comparison
Another consequence of the nearly unlimited duty-
cycle of a MALDI–LC/MS/MS experiment is that there
is no need for a predisposed bias to the intensity of the
peaks selected for MS/MS. In an ESI-LC/MS/MS ex-
periment, the software typically selects the peaks for
MS/MS in decreasing order of intensity; whereas, in the
equivalent LC-MALDI experiment, peaks may be se-
lected in the reverse order, from the least abundant
signal that meets the threshold criteria to the most
abundant. Additionally, the software on the 4700 Pro-
teomics Analyzer allows MS/MS spectra to be recorded
using either fixed or varying numbers of laser shots. In
the latter approach, a stop condition is applied in
addition to the maximum number of shots allowed. The
stop condition halts the data acquisition for the current
spectrum when its quality meets the criteria specified in
the stop condition. In others words, the instrument
performs a quality-dependent acquisition (QDA).
To evaluate the effect of different acquisition meth-
ods on the quality of the data acquisition, 170 fmole of
a tryptic digest of phosphorylase B were spotted on
each of several wells of a MALDI plate. An MS spec-
trum was recorded from each sample spot, and MS/MS
spectra for the 30 most abundant peaks present in each
spot were recorded in the order of highest to lowest
abundance. Spectra were acquired using either a fixed
number of laser shots (3000) or under QDA conditions.
In the case of the QDA acquisition, the maximum
number of laser shots acquired was 3000, the minimum
number of laser shots was 500, and the acquisition was
set to stop when the MS/MS spectrum being acquired
contained at least five fragment ions in the range from
m/z 400 to 90% of the precursor mass that had a S/N of
at least 10. The mass range used in the evaluation
excluded the immonium ions and other small fragment
ions from being considered in the S/N evaluation, since
these ions tend to be very strong but do not contain
much sequence specific information. The precursor and
fragment ions derived from the precursor by neutral
losses were also excluded.
In an analysis of phosphorylase B using the fixed-
shot MS/MS method, twenty one peptides were iden-
tified through database search using Mascot with a total
protein score of 940. In contrast, twenty six peptides
were identified using the method with a stop condition
with a total score of 895. The slightly lower score
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since fewer shots were accumulated for the easily
fragmented ions under QDA conditions. The spectra
from those ions had a lower average S/N and conse-
quently slightly lower Mascot ion scores. More impor-
tantly, more peptides were identified using the QDA
method. On average, fewer laser shots were fired (an
average of 1046 per spectrum) and, consequently, less of
the sample was consumed when recording spectra for
“well-behaved” peptides. In contrast, when using a
fixed number of laser shots, the sample may be com-
pletely consumed before having a chance to record
spectra for weak ions. Using a QDA method, the
instrument balances the number of shots used for both
the strong and weak ions, enabling generally good
spectra to be obtained for both of them. Additionally,
the time taken to finish the experiment is much shorter
for the QDA method. When accumulating 3000 shots
for each spectrum, it took 650 s to acquire all 30 spectra
(Note: the time required is longer than the simple
product of 3000 shots/spectrum  30/200 Hz laser
repetition rate because some sub-spectra were rejected
on the basis of poor quality and because the laser was
temporarily off between each sub-spectrum and spec-
trum). In contrast, the QDA method required only 447 s
to complete the acquisition of the 30 spectra. Thus an
incidental benefit of the QDA method is an increase in
throughput. However, the main benefit of this ap-
proach is the ability to get better data from a complex of
proteins in which some components are present at low
abundance and could thus be easily consumed under
conditions that employ a fixed number of laser shots.
The final fully optimized QDA method that was used in
subsequent experiments was described in the experi-
mental section.
Matrix Noise Filtration
CHCA is the most widely used MALDI matrix for the
analysis of peptides. It yields strong signals for many
peptides; however, it tends to form clusters that may
obscure peptides in certain regions of the mass range.
Furthermore, CHCA yields strong MS/MS signals (as
can be seen from the scanning MS/MS experimental
results shown in Figure 5) that can complicate the
interpretation of peptide spectra when the TIS is set in
the regions from m/z 600–650, m/z 850–900, and around
m/z 1100. In the case of the MS/MS acquisition, the only
practical solution found to date was to adjust the matrix
composition to minimize cluster formation. The addi-
tion of ammonium acetate to the matrix helps in this
regard. In principal, the TIS window can be narrowed
to reduce the amount of matrix background but this
also reduces sensitivity and is therefore not routinely
done.
The presence of matrix signals in MS spectra also
affects the ability of the Peak Picker software to effi-
ciently select ions for MS/MS analysis. Without any
filters, it was determined that the matrix signals wererepeatedly selected in different spots for subsequent
MS/MS analysis. Picking matrix signals for MS/MS
analysis has several negative consequences. First, low
intensity peptide ions may not be selected for MS/MS
analysis because the much stronger matrix ions fill the
quota specified for each spot by the Peak Picker soft-
ware. Second, the numerous matrix ions picked for
MS/MS analysis increase the time taken to complete the
analysis. Finally, the selection of matrix ions for MS/MS
increases the sample consumption for peptides present
in the same spot as selected matrix signals. In the
analysis of the ampicillin-based pull-down sample (see
below), it was determined that without a matrix back-
ground filter, roughly 50% of ions selected for MS/MS
analysis were matrix signals.
A strategy was devised to filter out matrix noise
from peptide ions based on the difference of their
fractional masses. Because of the limited elemental
composition for the 20 common amino acids, the masses
of peptides are not evenly distributed across the mass
range [35, 36]; rather the peptide masses are clustered
around specific values (Figure 6). In Figure 6, the
fractional masses for over 18,000 tryptic peptides in a
mass range of 600 to 2000 Da were plotted against their
nominal masses. The fractional masses for all peptides
with a similar mass are located in a narrow window
that ranges from 0.2 to 0.4 Da in width over the mass
range commonly employed for the MS/MS analysis of
tryptic peptides. For example, the peptides with a
nominal mass of 600 Da range in masses from approx-
imately 600.27 to 600.44 Da. As a general rule, the
fractional mass of a peptide is approximately equal to
the value of its nominal mass divided by 2000. The
fractional masses for CHCA clusters are also located
within a narrow window (Figure 6), which differs from
that of peptides. This difference was used to design a
filter to exclude the matrix signals from selection for
MS/MS analysis.
The peptide masses in the range from m/z 600 to
Figure 5. MS/MS analysis of the matrix background. The inten-
sity of the largest matrix ion in MS/MS spectra was plotted in the
mass range of 600 to 1400 Da. MS/MS spectra were recorded for
matrix alone from 600 to 1400 Da with a 10 Da window from 600
to 1200 Da, and 50 Da window from 1200 to 1400 Da. Intense peaks
were observed in the regions of 600-650 Da, 850 to 900 Da, and
around 1100 Da.
resu
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abundant, were further analyzed. Selected data points
located at the lower and the higher boundaries of the
fractional mass plot of Figure 6 were fitted with linear
equations. These equations define the boundaries for
peptide fractional masses. A mass filter file was created
with the help of those two equations, and is used to
filter out any molecules with fractional mass that fall
outside the two boundaries. This approach essentially
eliminates matrix clusters from MS/MS analysis.
Although matrix cluster ions were almost completely
eliminated from the selection list for MS/MS analysis,
matrix background can still pass through the TIS win-
dow when analyzing peptides with a mass similar to
that of the matrix clusters. Therefore, a more effective
way to suppress the formation of matrix clusters is still
preferred.
Statistical Analysis of TOF/TOF Data
The quantitative and qualitative aspects of peptide
identification from MS/MS data are intimately linked
with the fragmentation patterns generated from any
given peptide and with how those patterns are inter-
preted by a particular protein identification software
algorithm. Among other factors, the fragmentation pat-
terns are linked to the chemistry of the ionization
process and the physics of the MS instrument used in
the experiment. Since the ability to do many automated
MALDI-MS/MS experiments and the MALDI-MS/MS
instrument used in this study are both relatively new,
we explored the properties of the peptide MS/MS data
that was generated by the TOF/TOF. Additionally, the
interpretation of the data by Mascot was examined. The
body of data used in this case was derived from several
Figure 6. Peptide fractional mass analysis. Th
diamonds) and some matrix clusters (open circ
middle solid line represents the fractional mass
The two white lines are the linear fitting of selec
1200 Da. The two equations represent the fittinghundred analyses that were performed over the course
of approximately four months, and represent the anal-
ysis of over 130,000 peptides. In some cases, a smaller
data set out of the larger one was used and in all cases
only a subset of the acquired MS/MS spectra yielded
useful data. All of the samples were derived from
pull-down experiments using HeLa cell lysates; conse-
quently, the proteins that were analyzed were all hu-
man proteins.
Most of the peptide ions formed by ESI are multiply-
charged, and most of the MS/MS data from multiply-
charged peptides has been obtained under low-energy
(10–100 eV) collision conditions. The “mobile proton
model” of peptide fragmentation was proposed by
Wysocki and coworkers [37], in which low-energy CID
results in the so-called charge-directed fragmentation,
where cleavage occurs in the vicinity of a charge site.
Statistical analyses have been done to better understand
peptide fragmentation under low-energy collision con-
dition [38–40].
In contrast, MALDI produces predominantly singly-
charged ions and, in the case of the TOF/TOF, the
collision energy is typically in the range of 1000–2000
eV. With the large set of data obtained in our labora-
tory, it is possible for us to do some preliminary
statistical analyses to better understand peptide frag-
mentation under high-energy conditions which may
help improve the peptide matching algorithms. In any
case, a better understanding of the performance of the
TOF/TOF instrument makes it possible to improve the
design of experiments and to take full advantage of the
potential of this relatively new technology.
Peptide Score Analysis. Initially, a data set comprised of
55,000 MS/MS spectra was analyzed to see what kind of
ctional masses of over 18,000 peptides (black
ere plotted against their nominal masses. The
tained by dividing the peptide masses by 2000.
ata points at the two boundaries from 600 Da to
lts.e fra
les) w
es ob
ted d
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analysis. In this data set, about 90% of the precursor
ions have a mass less than 2000 Da, and about two-
thirds of the precursor ions have a cluster area of less
than 4000 (Table 2). The cluster area for an ion corre-
sponds to the combined area of all peaks in an isotope
cluster. The minimum cluster area that was specified in
Peak Picker analysis was 500, and the maximum cluster
area observed was in the range of 106 counts (Figure 7).
Since the cluster area of an ion is influenced greatly by
the laser power setting, and because the samples de-
rived from pull-downs were in themselves variable,
conditions were set to keep the ion signal consistent
across different plates; This was done by ensuring that
the signal intensity observed for the calibration stan-
dards spotted on each plate had an overall intensity of
about 2.0  104.
A plot of the Mascot ion score versus ion cluster area
is shown in Figure 7. With the Mascot settings em-
ployed in this study, ions with a score below 10 are
ignored. Consequently, the lowest ion score displayed
in Figure 7 is 10 and the maximum ion score is 223. The
majority of ions with a cluster area of 500 have a score
of less than 50. Conversely, as the precursor ion cluster
area increases above 10,000 counts, the proportion of
the ions with Mascot scores above 50 increases signifi-
cantly. This data suggests that, as expected, high inten-
sity ions generally produce better ion scores; however,
other factors, besides ion intensity, also affect the pep-
tide fragmentation and the resultant ion score.
A plot of ion score versus peptide mass is shown in
Figure 8. Generally, lower mass peptides yielded lower
ion scores. Furthermore, there is an apparent upper
Table 2. Peptide mass distribution
By mass By cluster area
m/z % cluster area %
1000 20.5 4000 65.3
1000–2000 66.2 4000–10,000 24.9
2000–3000 12.0 10,000 9.8
3000 1.3
Figure 7. The correlation between peptide ion scores and the ion
cluster area. About 22,000 data point were used in this analysis.score threshold for peptides of a specific mass, as
indicated by the solid line in Figure 8. This threshold
can be explained by the scoring algorithm employed by
the Mascot search engine. The Mascot matching algo-
rithm scores peptides based on the probability of a
given match being a random match. The more se-
quence-specific fragment ions that an MS/MS spectrum
is found to contain, then the lower the probability that
any peptide matched to that spectrum is a random
match. Generally, larger peptides have the potential to
produce more sequence-specific fragment ions com-
pared to smaller ones and, therefore, the potential
maximum scores for larger peptides will also be higher
than those for smaller peptides.
Peptide fragmentation is sequence-dependent, and
not all peptides produce intense sequence-specific frag-
ment ions in the TOF/TOF or other mass spectrometry
instruments. The overall peptide score distribution ob-
tained from analyzing 55,000 peptide spectra is shown
in Figure 9. The number of peptides of a given score or
higher decreases exponentially with increasing score.
Of the 55,000 peptides analyzed, about 60% have a score
Figure 8. The correlation between peptide scores and peptide
masses. The solid line indicates the upper limit of ion score for
most of the peptides with a specific size. About 47,000 data points
were used in the plot.
Figure 9. The cumulative percentage of ions with the specific
Mascot score and above. Only those with a Mascot score of 10 and
above are shown in the plot.
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0.6% for peptides with a score of 150 or higher.
In the Mascot scoring algorithm, the peptide score is
also related to the size of the database that is used. In
the case of this study, a match with an ion score of 37 is
considered to be identical or have extensive homology.
With this standard, about 20% of peptides produce
strong matches, and the matches with a score of 100 and
above account for about 6% of the overall searches. A
similar statistical analysis of MS/MS data derived from
an LCQ has been done [38]. In that case, the database
searching was done primarily using SEQUEST rather
than Mascot. The result indicated that 25% of doubly-
charged peptides and about 10% singly- and triply-
charged peptides produced good database search re-
sults, which is comparable with the overall success rate
obtained using the TOF/TOF.
Another characteristic of the Mascot scoring algo-
rithm is that each MS/MS spectrum is first matched
with up to 10 possible peptide sequences, each with a
potentially different confidence level. In a subsequent
step, Mascot generates a list of proteins which represent
the set of proteins that best accounts for most, if not all,
of the MS/MS spectra. The output of the program is a
ranked list of proteins that rapidly increases in length
with a decrease of the protein score threshold. Conse-
quently, it is critical to be able to determine an appro-
priate protein score threshold that represents a confi-
dent hit.
The 10 possible peptides that are matched to a
specific MS/MS spectrum all have the precursor mass
within the mass tolerance specified during the database
search. For high-scoring peptides, we determined that
most of those precursor mass errors were of similar
magnitude; whereas for low-scoring peptides, most of
the precursor mass errors differed greatly. As a conse-
quence, the peptide mass accuracy can be used, to some
degree, to evaluate the Mascot match. A plot of peptide
mass error versus peptide ion score is shown in Figure
10a. Most of the peptides with a relatively high ion
score (35) have a mass error within 50 ppm of the
expected mass. However, for peptides with an ion score
lower than 35, the mass accuracy generally decreases
dramatically. The score threshold of 35 shown in Figure
10a correlates very well with the Mascot statistical
significance score of 37. A plot of peptide mass error
versus the score of proteins that the peptide belongs to
is shown in Figure 10b. For high-confidence proteins
(score 100), most of the peptides have a mass error of
50 ppm. However, the mass accuracy decreases sig-
nificantly for many proteins with a score of 60 or less.
Based on this analysis, a protein score of 60 serves as a
useful first-pass threshold to consider the protein a
confident hit. Below that score, the low accuracy of the
matched assignments is likely to lead to a significant
number of false-positive identifications that can require
a significant amount of manual inspection or other
additional analysis to discriminate between correct and
incorrect protein identifications. For proteins withscores slightly above 60, it may still be necessary to
manually review the fit of the MS/MS spectrum to the
assigned peptide sequence in order to evaluate the
significance of the hit for that protein. However, the
relatively fewer number of proteins above that score
makes the task of manual review more tractable. With
the addition of other evaluation criteria, the task of
manual validation can be further reduced.
Analysis of High-Scoring Peptides. A database search of
the MALDI-MS/MS spectra using Mascot yielded a
subset of peptides that were identified with very high
confidence. In order to determine the unique character-
istics of the high-scoring peptides, 1252 peptides with a
Mascot ion score of 100 or above were subjected to a
more detailed analysis. The peptides in question ranged
in mass from 955 to 3994 Da, with a median mass of
1854 Da and an average length of 17 amino acids. The
1252 peptides are comprised of a total 22,031 amino acid
residues. Among these peptides, 583 are Lys-termi-
Figure 10. The plot of peptide mass error versus peptide ion
score (a) and versus protein score (b). The solid line in (a)
represents an ion score of 35, and the line in (b) represents a
protein score of 60.
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terminated with other amino acids. Most of the 1252
peptides contain a missed tryptic cleavage site, and
therefore contain more than one basic residue.
The frequencies of the appearance of the 20 common
amino acids in these high-scoring peptides are shown in
Table 3. Among the 20 amino acids, Glu, Gly, and Ala
were most frequently found in these high-scoring pep-
tides, and Trp, Cys, and Met were the least frequent. In
nature, the relative occurrence of the 20 amino acids
also varies. Consequently, a more relevant way to
compare the frequency of the amino acids in the high-
scoring peptides is in relation to the natural variation,
or at least with their variation in the databases used for
the analysis. Therefore, the frequencies of appearance
for the 20 amino acids in the 1252 peptides were
compared with their relative abundance in the NCBInr
and our HumanNR database (Table 3). At the time that
the experiment was performed, there were ca. 324
million and 33.4 million amino acid residues repre-
sented in the NCBInr and HumanNR databases,
respectively.
In Table 3, those residues with a ratio of percentage
relative abundance greater than one are over-repre-
sented in these high-scoring peptides. Conversely,
those with a percentage relative abundance less than
one are under-represented relative to the databases. The
initial comparison was made with the whole NCBInr
database. The protein sequences in that database are
derived from many species, including lower eukaryotes
Table 3. The frequency of appearances for amino acids in high-
Amino
Acid
Relative abundance
No. of
residues
High-
scoring
peptides
%
NCBI
%
Hu
A 1840 8.35 7.57 6
C 230 1.04 1.68 2
D 1439 6.53 5.04 4
E 2096 9.51 6.20 6
F 783 3.55 4.07 3
G 1864 8.46 6.96 6
H 449 2.04 2.31 2
I 1036 4.70 5.72 4
K 1213 5.51 5.64 5
L 1791 8.13 9.60 9
M 330 1.50 2.37 2
N 929 4.22 4.30 3
P 1062 4.82 5.12 6
Q 1093 4.96 3.98 4
R 713 3.24 5.36 5
S 1656 7.52 7.35 8
T 1202 5.46 5.74 5
V 1494 6.78 6.50 6
W 126 0.57 1.37 1
Y 685 3.11 3.12 2
*Those with underlines are under-represented by over 20%.
§Those in bold are over-represented by over 20%.
Including the 296 glycine residues present in the Gly-rich peptides.and prokaryotic species. Consequently, an additional
comparison was made with only human proteins be-
cause the relative abundance of certain amino acids
varies across species. This variation is evident in Table
3 from the fact that the ratios for A, C, E, F, I, N, P, Q,
and S differ by more than 10% between the two
databases.
When compared against the HumanNR database,
the residues Asp, Glu, Gly, and Ala are highly over-
represented (20%) in the high-scoring peptides. In
contrast, Trp, Cys, Arg, Met, and Pro are the signifi-
cantly (20%) under-represented residues. It has pre-
viously been observed that the presence of Asp and Glu
residues in a peptide sequence will enhance the selec-
tive cleavage of the peptide bonds on the C-terminal
side of those residues [41–43]. In the “mobile proton
model” of peptide fragmentation [37], the protons
present in the side chains of these acidic residues will
induce the bond cleavage, especially when the peptides
are terminated with an Arg residue. That model sug-
gests that the greater the number of acidic residues
present in a sequence, the more intense and compre-
hensive the fragment ions would be. The high-scoring
peptides identified in the LC-MALDI analyses per-
formed in this study are consistent with the “mobile
proton model” since the average number of acidic
residues per high-scoring peptide was approximately
three.
The over-representation of Gly residues in these
high-scoring peptides does not agree well with conven-
ng peptides and the comparisons with their natural abundances
Abundance comparison
High-scoring peptides/
NCBI ratio
High-scoring peptides/
human ratio
1.10 1.20
0.62* 0.47
1.30§ 1.38
1.53 1.40
0.87 0.98
1.22 1.23
0.88 0.82
0.82 1.10
0.98 0.99
0.85 0.84
0.63 0.71
0.98 1.18
0.94 0.77
1.25 1.04
0.60 0.57
1.02 0.88
0.95 0.98
1.04 1.12
0.42 0.42
1.00 1.07scori
man
%
.98
.24
.75
.78
.62
.89
.50
.29
.54
.69
.12
.56
.22
.77
.63
.52
.57
.05
.35
.90
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two or more consecutive Gly residues in a sequence,
abundant fragment ions are not generally observed
from the cleavage between these residues [44]. Detailed
analysis of the 1252 peptides reveals that 20 peptides
contain a total of 296 Gly residues, with an average of 15
Gly residues per peptide. These 20 peptides are primar-
ily from keratins and heterogeneous nuclear ribo-
nucleoproteins, which are often the relatively abundant
contaminant proteins in our samples. In this case the
high representation of the Gly residues in the high-
scoring peptides is likely an artifact of the abundant
contaminating proteins which happen to be rich in
glycine residues. Without including these 296 Gly resi-
dues in the statistical analysis, the ratio of Gly residues
in the remaining peptides is in line with its natural
abundance. As previously observed [44] under low-
energy collision conditions, these Gly-rich peptides did
not yield abundant fragment ions. Nevertheless, many
nearly complete low abundance y-ion series were pro-
duced by the TOF/TOF, which were sufficient to yield
high-confidence peptide identifications. As expected,
when spectra for the same peptides were generated by
the LCQ, the ion scores obtained for most of the
peptides were generally much lower than the equiva-
lent results from the TOF/TOF.
The presence of a Pro residue in a peptide has been
observed to enhance peptide bond cleavage on its
N-terminal side [39]. In these high-scoring peptides, the
frequency of appearance for Pro residues is similar to
that in the NCBInr database, and is under-represented
as compared to the HumanNR database.
Trp and Met residues are the least-abundant residues
present in nature, and they are also severely under-
represented in the high-scoring peptides. Trp and Met
are two amino acids which can be readily oxidized.
During each database searching, the oxidation of Met
was selected as a variable modification, whereas the
oxidation of Trp was not. Met residues were observed
both as modified and unmodified forms in these high-
scoring peptides. For a given peptide, the oxidation of
methionine didn’t seem to affect its score, suggesting
that the low frequency of appearance for Met observed
in these high-scoring peptides is not due to oxidation.
The oxidization of Trp is even less frequent than for
Met, so the failure to select the oxidation of Trp during
a database search cannot fully explain the extremely
low frequency observed in the case of Trp. This data
suggests that the presence of these two residues may
hinder the peptide fragmentation; however, this conclu-
sion still needs to be validated with more experiments.
Cysteine is also severely under-represented in these
high-scoring peptides, and this fact suggests that the
cysteine-containing peptides isolated using specific en-
richment methods [45] may not produce the best
fragmentation.
Arginine is another residue under-represented in
these high-scoring peptides. Early studies have shown
that Arg-terminated peptides tend to give much stron-ger signals in MALDI MS analysis [46–48], and tends to
produce less fragmentation in the MS/MS analysis
because the proton is trapped at its basic side chain [48].
This conclusion is in general agreement with the result
obtained from analyzing the high-scoring peptides.
However, it is interesting to note that among the 1252
peptides, about an equal number of them are Lys- and
Arg-terminated. Further analysis of the 635 Arg-termi-
nated peptides shows that 310 peptides also contain a
lysine residue in the sequence. So it is possible that, in
these Arg-terminated peptides, the charge may some-
times be located in the lysine residue rather than in the
arginine. Furthermore, the presence of acidic residues
in the Arg-containing peptides can still result in better
peptide fragmentation.
Applications of LC-MALDI to the Analysis
of Protein Complexes
Ampicillin pull-down. Our optimized LC-MALDI
method was first applied to the analysis of an E. coli
protein complex obtained from a drug-based pull-down
that used ampicillin as the bait.
In this model system, the interaction between ampi-
cillin and the penicillin-binding proteins (PBPs) is well
understood [50]. In E. coli, ampicillin will irreversibly
inhibit the activities of peptidoglycan transpeptidases,
which are involved in the synthesis of the peptidogly-
can layer of the cell wall. That inhibition is the result of
the covalent attachment of ampicillin to the PBPs,
which eventually leads to cell death.
In the experiment described herein, when the immo-
bilized ampicillin was incubated with solubilized E. coli
membranes, the PBPs formed a covalent bond with the
ampicillin, which allowed essentially all other proteins
in the lysate to be removed through stringent washing.
After washing, an aliquot of the ampicillin beads was
resuspended in SDS sample buffer and was boiled for
1 h, prior to SDS-PAGE gel analysis (Figure 11). In the
silver stained gel, only 5–6 distinct bands were visible
in the lane corresponding to the ampicillin pull-down
sample. Another aliquot of the beads, corresponding to
three times the amount used in the gel analysis, was
digested with trypsin, and the sample was analyzed
using 1D LC-MS/MS without CEX fractionation. The
estimated protein amount used in the digestion is about
1–2 g, as determined by comparing the bands from the
PBPs with the protein standards in the gel.
Besides some high abundance ribosomal proteins,
which bind to the beads non-specifically, nine known
penicillin-binding proteins, from PBP 1A to PBP 7, were
identified, with eight of those proteins identified with
high confidence (Table 4). Among them, PBP 1A has the
highest score and sequence coverage, and PBP 1C has
the lowest score and sequence coverage. PBP ampH, a
beta-lactamase, that inactivates ampicillin by catalyzing
the opening and hydrolysis of its beta-lactam ring, was
also identified with a relatively low score.
In E. coli, the nine known PBPs are expressed at
818 ZHEN ET AL. J Am Soc Mass Spectrom 2004, 15, 803–822varying levels, with PBP 1C present at about 5–10
copies per cell [51] and the other proteins in the range of
hundreds to thousands of copies per cell [52]. In gen-
eral, the Mascot scores for the detected PBP’s mirror the
amount of the protein in the lysate. The low score
obtained for PBP ampH is likely due to the low abun-
dance of the protein present in the final sample. Unlike
the other PBPs, the interaction between ampicillin and
PBP ampH is not covalent, and the stringent washing
conditions used in the experiment may severely reduce
the concentration of PBP ampH as analyzed by MS. The
protein silver stain method used in Figure 11 has a
lower detection limit of approximately 15 fmole for BSA
in our hands. The lower limit of detection for PBP 1C
and PBP ampH may be different from that of BSA due
to their different amino acid compositions. Neverthe-
less, the identification of these low abundance proteins,
which were invisible from SDS-gel analysis (Figure 11),
suggests that the optimized LC-MALDI method has a
Figure 11. SDS-PAGE analysis of the pull-down samples using
GRB2 (a) and ampicillin (b) as baits. The gels were stained using
silver stain, and the molecular weights markers are shown.
Table 4. Database search results for ampicillin interaction prote
Name
Protein
reference
Mass
(kDa)
Ma
sc
PBP 1A giP7428842 94.5 4
PBP 1B giP26246094 94.3 2
PBP 1C giP2497585 85.1
PBP 2 giP42316 70.9 2
PBP 3 giP15799768 63.9 2
PBP 4 giP16131072 51.8
PBP 5 giP1778549 46.9 1
PBP 6 giP2506804 43.6 2
PBP 7 giP13362490 34.2
PBP ampH giP26106773 41.9
aThe peptides identified for PBP 1C and PBP ampH are different ones.good sensitivity and dynamic range with a limit of
detection in the low femtomole range or better.
GRB2 pull-down analysis. The ampicillin-E. coli system
was a good model to explore the LC-MALDI method
we developed, but it was not very challenging because
of the limited complexity of the E. coli proteome. We
therefore applied the LC-MALDI method to the analy-
sis of a pull-down performed with a tandem affinity-
tagged protein bait [53, 54] derived from growth factor
receptor-bound protein 2 (GRB2). GRB2 is a relatively
small protein that contains an SH2 domain surrounded
by two SH3 domains. The presence of these common
structural motifs allows GRB2 to participate in many
protein-protein interactions [40], which yield a pull-
down with many interactors; those interactors cover a
wide range of concentrations. None of the interacting
proteins in question form a covalent bond with the bait
and, consequently, are susceptible to loss during the
washing steps of the pull-down procedure. Addition-
ally, the lysate used in this pull-down was derived from
HeLa cells (a human cervix carcinoma cell line) and was
therefore much more complex than the E. coli lysate.
Using such a complex lysate results in a pull-down that
is inherently more dirty with many non-specific inter-
actors. Finally, to increase the efficiency of the pull-
down, a large excess of bait is used. A significant
amount of this bait ends up in the final eluent, yielding
a protein complex in which the bait can comprise up to
50% (Figure 11) of the total protein content. All of these
factors combine to make the GRB2 pull-down analysis a
more stringent test of the LC-method. Furthermore, to
provide an element of external validation, a duplicate
set of GRB2 pull-down samples was analyzed by an
analogous 2D LC method using an LCQ Deca XP.
In the LC-MALDI analysis, since the peptides are
only picked at their most concentrated spots for
MS/MS analysis, the high abundance peptides derived
from GRB2 theoretically will only be analyzed once.
However, a detailed analysis of the GRB2 data obtained
using TOF/TOF indicates that the 34 peptides identi-
fied for GRB2 were analyzed a total of 85 times, yielding
a ratio of 2.5 for the total peptides to the non-redundant
om 10 LC-MALDI
No. of
peptides Coverage
Averaged
peptide score
48 77% 90.0
36 50% 81.2
2a 2% 27.2
34 70% 65.9
31 69% 75.7
9 28% 42.9
18 50% 62.7
28 72% 100.3
11 46% 81.7
2a 7% 27.8ins fr
scot
ore
311
922
54
238
342
386
128
808
899
54
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were due to several factors. First, the same peptides
were found to be present in more than one CEX
fraction. Second, for some methionine-containing pep-
tides, both the Met-oxidized and the non-oxidized
forms of the same peptide were found to be present in
the samples; Mascot reports these as a single peptide.
Third, some peptides, for unknown reasons, were
found to be present in two or more spots far away from
each other in the same LC-MALDI plate; as a result,
Peak Picker software treats them differently and they
were picked multiple times for MS/MS analysis. In the
case of the LCQ, 26 peptides identified from GRB2 were
analyzed 201 times, yielding a ratio of 7.8 for the total
peptides to the non-redundant peptides. The three
factors discussed above undoubtedly contribute to the
high ratio observed during the ESI-based analysis;
still, the LCQ spends significantly more time in
analyzing the most abundant proteins, which, in turn,
limits its ability to analyze weak ions present in the
sample.
Given the factors described above, the degree of
separation achieved in the first LC dimension can have
a significant impact on the success of the overall LC/
MS/MS experiment. To evaluate the effect of varying
the number of CEX fractions collected on the overall
success of protein identification, replicate pull-downs of
GRB2 were analyzed by both MALDI-LC/MS/MS and
ESI-LC/MS/MS. Results were compared for methods
that employed two, three, or six CEX fractions.
When analyzing TOF/TOF MS spectra using the
Peak Picker software, an average of 2133 ions were
selected for MS/MS in the two-CEX-fraction method.
With the three- and six-CEX-fraction methods, the num-
ber of ions selected was 2282 and 2345, respectively. As
expected, more peptides were resolved with the in-
creasing number of CEX fractions collected during the
first dimension separation. However, the difference in
the number of ions detected between two-, three-, and
six-fraction methods is minimal. Furthermore, the over-
all Mascot scores and the numbers of non-redundant
peptides identified for several GRB2 interactors are
very similar (Figure 12), suggesting that the two-CEX-
fractions collected in the first-dimensional separation
is more than adequate in the case of the GRB2
analysis.
In the ESI-based analysis of GRB2, the number of
peptides identified for high abundance proteins like
GRB2 and Dynamin 2, was essentially the same regard-
less of the number of CEX fractions collected in the first
dimension (Figure 13). However, when only two CEX
fractions were collected, several low abundance pro-
teins (e.g., c-cbl, DOCK180) were not detected. The
differences between the results obtained from the six-
and two-CEX-fraction methods are attributed to a com-
bination of ion suppression and the limited duty cycle
of the LCQ.
The comparison of the protein scores and the num-
ber of non-redundant peptides identified for GRB2interactors obtained using the LCQ and the TOF/TOF
are shown in Figure 14a and b. The LC-MALDI method
identified more peptides than ESI-based method, and
the protein scores were also generally higher. The
average peptide ion score for GRB2 interactors obtained
using the LCQ is about 42, and the corresponding score
obtained using TOF/TOF is about 51, suggesting the
quality of the MS/MS spectra obtained using TOF/TOF
is generally higher. Given that the LC-MALDI approach
identified more proteins with better scores using fewer
CEX fractions than the ESI analysis of the same
samples, it is believed that MALDI-based approach is
an excellent strategy for the analysis of protein
complexes.
Figure 12. The Mascot scores (a) and the number of non-
redundant peptides (b) identified for several selected GRB2 inter-
actors with LC-MALDI using different CEX separation methods.
The plots show the averaged results for two replicates with 2-, 3-,
and 6-CEX fraction methods.
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Ionization
The data presented above suggests that an LC-MALDI
approach to protein identification can provide some
benefits relative to a similar ESI-based approach. How-
ever, what can’t be overlooked is the complementary
Figure 13. The number of non-redundant peptides identified for
selected GRB2 interactors using an LCQ Deca XP on samples
separated into 2 and 6 fractions during strong cation-exchange
separation.
Figure 14. The Mascot scores (a) and the non-redundant pep-
tides (b) identified for several selected GRB2 interactors using
LCQ and TOF/TOF and the combined results from the two
instruments. The LCQ data are from analyzing the samples from
6-CEX-fraction methods, and the TOF/TOF data shown here are
from samples from 2-CEX-fraction methods.nature of the two ionization processes. The ionization
mechanisms are fundamentally different, and it has
been well-established that the set of tryptic peptides
detectable by the two approaches is not identical [29].
Consequently, we evaluated the benefits of combining
the two LC/MS/MS approaches for protein identifica-
tion.
In the GRB2 pull-down analysis, although the TOF/
TOF generally identified more peptides from the inter-
actors than the LCQ, some peptides were uniquely
identified using only one of the systems (Figure 15). It is
interesting to note that although six peptides were
identified for c-cbl using either the TOF/TOF or the
LCQ, none of these peptides overlap. The combination
of the data obtained using both systems gives even
higher Mascot scores, higher protein coverage, and an
overall higher confidence (Figure 14). The combined
data is not significantly different from the individual
result for proteins with relatively high scores, like
Dynamin 2 or GRB2 (Figure 14). However, for those
proteins whose identification may be somewhat tenu-
ous, the combination of the results from both MALDI
and ESI brings the total scores for these uncertain
proteins into a range where they can be identified with
confidence. For example, in the case of c-cbl, the com-
bination of the results from both the TOF/TOF and the
LCQ increases the score from about 240 for both instru-
ments alone to a total 485. This is a score that makes it
possible to confidently conclude that c-cbl is properly
identified and is a real interactor of GRB2 [55]. Addi-
tionally, Cas-Br-M b and SOS were only identified in
the LC-MALDI results with five and four peptides with
a score of 95 and 62, respectively. However, the protein
scores from the combined peptide level TOF/TOF and
LCQ data were 105 and 94 for Cas-Br-M b and SOS,
respectively (Figure 14a). The combined results con-
tained six peptides for each protein (Figure 14b). The
presence of the additional peptides in the combined
Figure 15. Comparison of the number of unique and common
peptides identified using ESI-LC/MS/MS and LC-MALDI-
MS/MS for GRB2 and several interactors.
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the LCQ data that, by themselves, did not yield suffi-
cient confidence for the corresponding proteins to make
it into the final Mascot output list. Thus the combined
result from the MALDI and ESI experiments is both
more confident and comprehensive.
Conclusions
The application of LC-MALDI-TOF/TOF to the analysis
of protein complexes was demonstrated in this study.
Many of the individual steps in the sample handling
and analysis process, from trypsin digestion to MALDI-
TOF/TOF data acquisition, have been optimized. The
sensitivity and the dynamic range of the method were
demonstrated by successfully identifying all of the
known penicillin-binding proteins obtained via an am-
picillin-based pull-down from an E. coli lysate. The
essentially unlimited decision-making time afforded by
the MALDI-LC/MS/MS-based approach yields less re-
dundant, higher quality MS/MS spectra than might
otherwise be achieved. The resultant effective increase
in the duty-cycle of the MS/MS analysis also enables
the use of fewer CEX fractions prior to the RP-HPLC
separation than in a comparable ESI-based experiment.
An evaluation of the MALDI-MS/MS results showed
that about 20% of the MS/MS spectra from the TOF/
TOF produce excellent peptide matches. Under the
high-energy collision conditions used in this study,
acidic residues were found to be over-represented in
these high-scoring peptides, and Trp, Cys, Arg, and Met
residues were under-represented.
In the analyses of the protein complexes, generally,
more peptides were identified for GRB2 interactors
using TOF/TOF than from LCQ. This may be a function
of differing fundamental sensitivity of the two instru-
ments. Regardless of the difference in MS/MS data
resulting from any differences in the performance of the
instrument platforms, some precursor ions were only
observed in one ionization mode or the other. Conse-
quently, the combination of the data obtained using
both systems gives higher Mascot scores, higher protein
coverage, and an overall higher confidence than if only
one platform was used.
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